Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
27.08
+1.53 (5.99%)
Dec 6, 2024, 4:00 PM EST - Market closed

Spyre Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1,59077528234377221
Upgrade
Market Cap Growth
2920.19%2701.10%-88.19%-37.90%70.36%23.39%
Upgrade
Enterprise Value
1,331959-41127243138
Upgrade
Last Close Price
27.0821.5211.25118.75196.75191.00
Upgrade
PS Ratio
-874.9111.8812.50--
Upgrade
PB Ratio
8.114.210.552.792.703.69
Upgrade
P/TBV Ratio
8.73-0.552.792.703.69
Upgrade
EV/Sales Ratio
-1082.03-6.78--
Upgrade
Debt / Equity Ratio
--0.090.070.040.09
Upgrade
Asset Turnover
-0.000.030.14--
Upgrade
Quick Ratio
7.2310.613.834.668.903.92
Upgrade
Current Ratio
7.3210.684.254.919.114.06
Upgrade
Return on Equity (ROE)
-91.62%-289.17%-124.87%-58.81%-80.93%-122.74%
Upgrade
Return on Assets (ROA)
-38.81%-35.60%-58.53%-30.22%-41.61%-62.40%
Upgrade
Return on Capital (ROIC)
-51.98%-61.52%-73.41%-34.95%-48.37%-75.71%
Upgrade
Earnings Yield
-13.52%-43.71%-302.87%-28.09%-21.44%-35.34%
Upgrade
FCF Yield
-9.51%-12.89%-289.74%-23.17%-21.22%-30.34%
Upgrade
Buyback Yield / Dilution
-845.79%-104.59%-28.19%-23.18%-67.05%-53.44%
Upgrade
Total Shareholder Return
-845.79%-104.59%-28.19%-23.18%-67.05%-53.44%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.